文献速递牙周病

纳米驱动双通路铁死亡抑制治疗糖尿病牙周炎

Nano-Driven Dual Ferroptosis Inhibition for Diabetic Periodontitis Therapy.
PubMed 文献 · J Dent Res · 2026-02-11

糖尿病牙周炎治疗面临挑战,铁死亡在其病理中起重要作用。研究构建双金属ZIF-8共递送纳米平台FGZ NPs,缓释镓离子与铁死亡抑制剂Fer-1,协同激活Nrf2/HO-1通路恢复铁稳态并增强抗氧化,实现双通路铁死亡抑制,显著促进牙周组织再生。

要点

  • FGZ NPs通过缓释Ga³+与Fer-1实现双通路铁死亡抑制。
  • FGZ NPs激活Nrf2/HO-1通路,恢复铁稳态并增强抗氧化。
  • FGZ NPs显著促进糖尿病牙周炎模型受损牙周组织再生。

核心结论

  • 铁死亡是糖尿病牙周炎的有前景治疗靶点,双通路抑制策略优于单通路抑制剂。

研究设计与样本

  • 工程化双金属ZIF-8共递送纳米平台FGZ NPs,缓释镓离子与铁死亡抑制剂ferrostatin-1。

主要发现

  • FGZ NPs有效激活Nrf2/HO-1细胞保护通路,同时重建铁稳态并增强抗氧化能力。
  • FGZ NPs实现双通路铁死亡抑制,显著促进受损牙周组织再生。

临床怎么用

  • 为糖尿病牙周炎提供靶向铁死亡的双通路纳米治疗策略,超越单通路抑制剂局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic periodontitis constitutes a serious and multifaceted public health issue, acting as a significant risk factor for various systemic diseases by exacerbating inflammatory responses and disrupting metabolic stability. Its high prevalence, severe periodontal tissue destruction, and complex pathological mechanisms present substantial therapeutic challenges. Conventional therapies frequently fail to target underlying molecular pathological mechanisms. Ferroptosis, an iron-dependent form of regulated cell death characterized by iron accumulation and lipid peroxidation, has been increasingly implicated in diabetic periodontitis. However, translating ferroptosis inhibition into effective therapy remains problematic. Current strategies, primarily relying on single-pathway inhibitors, exhibit insufficient effectiveness. To overcome this, we engineered a bimetallic ZIF-8 codelivery nanoplatform (FGZ nanoparticles [NPs]) for sustained release of gallium ions (Ga³+) and canonical ferroptosis inhibitor ferrostatin-1 (Fer-1), synergistically integrating the functions of the 2 drugs. FGZ NPs potently activated the Nrf2/HO-1 cytoprotective pathway, simultaneously reestablishing iron homeostasis and strengthening antioxidant capacity, resulting in effective dual-pathway ferroptosis inhibition. FGZ NPs demonstrated outstanding therapeutic outcomes, significantly promoting the regeneration of damaged periodontal tissues. This study validates ferroptosis as a promising target for diabetic periodontitis and introduces a novel strategy that surpasses the constraints of single-pathway ferroptosis inhibition, providing a new design framework for biomaterials targeting ferroptosis-related diseases.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Zhao Z, Feng H, Wang X, et al. Nano-Driven Dual Ferroptosis Inhibition for Diabetic Periodontitis Therapy. J Dent Res. 2026. PMID: 41673535. doi:10.1177/00220345251409777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。